Uganda medical device registration timeline

Source-linked clocks

National Drug Authority (NDA) (NDA) review clocks and end-to-end planning ranges, using the 4-class (A, B, C, D) — NDA's own risk axis from Class A (low risk) to Class D (high risk, where the risk relates to the patient or to public health), applied from the classification rules in DAR/GDL/028 Rev 0 (Appendix VII and Table 1); every device must be registered before importation or supply regardless of class classification system.

1 pathways1 of 1 clocks verifiedvalidity Two answers are published and they disagree, so both are carried. S.I. 2014 No. 29 reg. 40(1) gives a first registration certificate five years and a renewal certificate one year from issue, with renewal to be filed at least 90 days before expiry (reg. 42(1)). NDA's registration guideline states the opposite term — that registration or listing of a surgical instrument or appliance 'remains valid unless it is suspended, revoked or terminated', subject to the annual retention fee and to annual post-marketing surveillance and adverse-effect reports for products NDA treats as high risk or requiring special attention (DAR/GDL/028 §§4.5-4.7, 4.14). Whether S.I. 77 of 2019 of the Surgical Instruments and Appliances Regulations changed either is unresolved: that instrument could not be retrieved on any transport and is not published on NDA's own legislation page.MDSAP not acceptedreviewed 2026-09-16nda.or.ug

Class / pathway	Review clock	Planning total	With prior approval	Provenance
Surgical instruments and appliances — registration by the Authority(Application to the National Drug Authority for registration of a surgical instrument before manufacture, importation or exportation, on Form 7 of Schedule 6 to S.I. 2014 No. 29 (reg. 27(1)-(2)), filed by the patent holder, a licensed person, the manufacturer, or an agent authorised by the manufacturer or patent holder (reg. 27(3)); registration is a precondition of sale or distribution (reg. 25(1))) Reg. 38(1) of the National Drug Policy and Authority (Registration) Regulations, 2014 (S.I. 2014 No. 29), Part IV: 'The Authority shall determine an application for registration under these Regulations, within sixty days from the date of receipt of the application.' It is the only clock in the instrument that runs against the Authority, and reg. 38(2)-(4) name the three decisions it governs — approve and register, require further information, or refuse with reasons.	60 days	2-6 months	—	Verified

Review clocks exclude applicant hold time · planning totals are estimates

Planning steps and estimates; these are not regulator deadlines.

Uganda Medical Device Registration Process

Step-by-step NDA registration process. Total estimated timeline: 2-6 months.

Step 1: Pre-Submission Preparation

1-3 months

Gather technical documentation, quality management system (QMS) records, and clinical data required by NDA. Appoint a Authorised local technical representative in Uganda, which must declare responsibility for every application and is the party that submits corrected or new artwork; reg. 27(3) of S.I. 2014 No. 29 does not itself require the applicant to be resident in Uganda, so the operative local-actor requirement is the technical-representative declaration in DAR/GDL/028 §4.3.1..

Step 2: Application Submission

1-2 weeks

Submit complete registration dossier to NDA including device description, risk analysis, and testing reports.

Step 3: Administrative Review

2-4 weeks

NDA reviews application for completeness. May request additional documents or clarifications.

Step 4: Technical Evaluation

60 days

In-depth technical assessment of device safety and performance. NDA may issue questions.

Step 5: Registration Approval

1-2 weeks

Upon successful review, NDA issues Uganda market authorization certificate.

Summary: The Uganda medical device registration process through National Drug Authority (NDA) (NDA) consists of 5 main steps: Pre-Submission Preparation → Application Submission → Administrative Review → Technical Evaluation → Registration Approval.

Prior approval recognition

Licence or approval from an IMDRF founding-member country — Australia, Canada, the European Union, Japan, the United StatesTrack 1: an abridged evaluation in which the foreign approval carries the technical assessment, with a much smaller submission (attestation, abbreviated product and manufacturer details, notarized copy of the licence, Certificate of Analysis to an accepted quality-system standard, evidence of repeat sales and product samples where practicable). It is an expedited review with shortened registration timelines, but NDA publishes no number for the shortening and the final decision remains NDA's.

WHO Prequalification, or quality-system certification from a certification body accredited by a regulatory authority in an IMDRF founding-member country, or any other international organisation recognised by NDATrack 2: accepted as a documentary substitution for an IMDRF-country licence under DAR/GDL/028 §4.12.2 — the foreign element that unlocks the route is the quality-system certification and its accreditation rather than a product approval, and no shortened period is published for it.

Recognised-country certification or CE certification — an eligibility gate for classes B, C and DDAR/GDL/028 §4.11 makes certification from a recognised country (United States, Canada, Japan, Europe) or CE certification mandatory for classes B, C and D: devices not certified by any recognised country will be examined and may be exempted from the requirement only if they are class A. The European certificate required scales with class — full quality assurance or EC Type Examination Certificate for classes B and C, and full quality assurance or EC Design Examination Certificate for class D, from a notified body approved by European health authorities. This is a gate, not a fast track: it conditions eligibility and shortens nothing by itself.

China NMPA registration certificateChina is not on NDA's recognised-country list, which is closed: DAR/GDL/028 §4.11 enumerates the United States, Canada, Japan and Europe, Table 2 names Australia, Canada, the European Union, Japan and the United States, and the medical-devices page names the same five. An NMPA registration therefore does not put a product into Track 1 and does not satisfy the §4.11 gate for classes B-D; a Chinese-manufactured device reaches Uganda through Track 2 or Track 3, and the country-of-origin marketing approval must still be legalised and filed in every case.

Key requirements

All surgical instruments and appliances must be registered by the Authority before they are sold or distributed (reg. 25(1) of S.I. 2014 No. 29), on Form 7 of Schedule 6 (reg. 27(2)); the application may be made by the patent holder, a licensed person, the manufacturer, or an agent authorised by the manufacturer or patent holder (reg. 27(3)), and the particulars the application must contain are listed in reg. 27(4)(a)-(l).
A declaration by the authorised local technical representative of the applicant must be submitted for all applications, undertaking that the submitted documents are an accurate reflection of truth, that the representative is fully responsible for the product and the post-market plan for complaint handling or recall, and that it will comply with NDA's post-market requirements; the local technical representative is also the party that must submit corrected or new artwork where NDA requires it, and a product will not get marketing approval until the Local Technical Representative in Uganda submits the artwork with a sample from the first consignment (DAR/GDL/028 §4.3.1).
For classes B, C and D, certification from a recognised country or CE certification is mandatory and only class A may be exempted from it (DAR/GDL/028 §4.11); the European certificate required scales with class, and the notified body must itself be approved by European health authorities.
A separate and complete dossier in electronic form is required for each surgical instrument, appliance, group or family, with two content sets: for class A, the filled application form, letter of authorization, IFU and promotion material, labelling information, sterilization information where applicable and proof of a quality management system such as ISO 13485; for classes B, C and D, the filled application form, letter of authorization, appliance details, a summary of technical documentation, labelling information, evidence of conformity to the Essential Principles checklist and the quality-system proof (DAR/GDL/028 §4.3.3.1).
Labelling must carry nine elements — the name of the instrument, the manufacturer's name and address, the instrument identifier, package contents where not readily apparent, the word 'Sterile' where applicable, the expiry date, the medical conditions, purposes and uses, the directions for safe and effective use and any special storage conditions — provided in English, permanently and prominently, in terms easily understood by the intended user (regs. 29(1)-(2) and 35).
Gazetted fees apply: under the National Drug Policy and Authority (Fees) Regulations, 2025 (S.I. 2025 No. 67, in force 1 October 2025, revoking the 2022 Fees Regulations) first registration of an imported surgical instrument is US$1,500 and of a locally manufactured one US$200; annual retention is US$200 for an imported device and US$100 for a locally manufactured one; a major amendment of an imported-device application is US$500, a minor amendment US$200 and a notification of amendment US$50. Fees are non-refundable and payable on application, and NDA will not receive an application for which the fee is unpaid.
Renew before expiry: the renewal application must reach the Authority at least 90 days before the registration expires, in writing, with a consolidated report of the changes made during the registration's validity whether or not they were reported, a report of adverse reactions detected during the product's lifetime, five samples of the packaging in the form in which it is to be marketed and the prescribed fee (regs. 42(1)-(2)).
Keep the registration in force: an annual retention fee must be paid to remain on the Register and annual post-marketing surveillance reports must be submitted for products NDA treats as high risk or requiring special attention, with adverse-effect reports; a registration may be terminated by the registrant on 30 days' written notice with reasons, and NDA may suspend or revoke a registration, or amend its conditions, giving reasons in writing (S.I. 2014 No. 29 reg. 40 and DAR/GDL/028 §§4.5-4.7, 4.14).
Answer a query: processing halts once a query or request is raised and resumes on the response, and an application may be cancelled or rejected if no response is received within six months of the written query notification date (DAR/GDL/028 §4.3.1).

Primary regulator sources

nda.or.ug · National Drug Authority — Drug Registration Regulations, 2014 (S.I. 2014 No. 29), regs. 38 and 42 made under the National Drug Policy and Authority Act, Cap. 206

Reviewed 2026-09-16. End-to-end totals remain planning estimates.

Keep researching this market

View the Uganda resource hub →

Compare timeline across all countries →

Continue with this market

Source-linked review clocks verified against NDA publications · full review 2026-09-16 · row IDs are stable — cite as registration-timeline:uganda:surgical-instruments-registration